141 related articles for article (PubMed ID: 19350168)
1. [Thrombotic thrombocytopenic purpura: experience in 18 cases and literature review].
Eymin G; Andrade M; Andresen M; Pereira J
Rev Med Chil; 2008 Dec; 136(12):1518-27. PubMed ID: 19350168
[TBL] [Abstract][Full Text] [Related]
2. [Activity loss of Von Willebrand factor cleaving protein (ADAMTS-13) is diagnostic for primary and pregnancy-related thrombotic thrombocytopenic purpura].
Hulstein JJ; Rison CN; Kappers-Klunne MC; Hene RJ; Franx A; de Groot PG; Brand A; Fijnheer R
Ned Tijdschr Geneeskd; 2004 Oct; 148(40):1972-6. PubMed ID: 15524133
[TBL] [Abstract][Full Text] [Related]
3. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
Shibagaki Y; Fujita T
Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
[TBL] [Abstract][Full Text] [Related]
4. Incidence of obstetrical thrombotic thrombocytopenic purpura in a retrospective study within thrombocytopenic pregnant women. A difficult diagnosis and a treatable disease.
Delmas Y; Helou S; Chabanier P; Ryman A; Pelluard F; Carles D; Boisseau P; Veyradier A; Horovitz J; Coppo P; Combe C
BMC Pregnancy Childbirth; 2015 Jun; 15():137. PubMed ID: 26081109
[TBL] [Abstract][Full Text] [Related]
5. [A woman suffering from systemic lupus erythematosus and acquired thrombotic thrombocytopenic purpura].
Verheijen FM; Reedijk L; Fijnheer R
Ned Tijdschr Geneeskd; 2004 Oct; 148(40):1977-81. PubMed ID: 15524134
[TBL] [Abstract][Full Text] [Related]
6. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
Furlan M
Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):243-55. PubMed ID: 15030284
[TBL] [Abstract][Full Text] [Related]
7. Analysis of clinical and laboratory characteristics in 42 patients with thrombotic thrombocytopenic purpura from a single center in China.
Deng MY; Zhang GS; Zhang Y; Xiao H; Dai CW; Xu YX; Zheng WL; Peng HL; Shen JK
Transfus Apher Sci; 2013 Dec; 49(3):447-52. PubMed ID: 23973730
[TBL] [Abstract][Full Text] [Related]
8. [The clinical studies of 51 patients with thrombotic thrombocytopenic purpura].
Sun L; Yu Z; Bu Y; Su J; Wang C; Cao L; Bai X; Wang Z; Ruan C
Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):147-51. PubMed ID: 24606658
[TBL] [Abstract][Full Text] [Related]
9. [New marker in thrombotic thrombocytopenic purpura].
Gøtze JP; Hillarp A; Lindblom A; Björk P; Strandberg K; Nielsen LB
Ugeskr Laeger; 2008 Aug; 170(33):2446-9. PubMed ID: 18761827
[TBL] [Abstract][Full Text] [Related]
10. Post-appendectomy thrombotic thrombocytopenic purpura: a case report and review of the literature.
Robertson MD; Zumberg M
Am J Hematol; 2007 Mar; 82(3):224-8. PubMed ID: 17034025
[TBL] [Abstract][Full Text] [Related]
11. [Clinical analysis of 14 patients with thrombotic thrombocytopenic purpura].
Wang Y; Zhang JY; Niu ZY; Lin FR; Zhou JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):407-11. PubMed ID: 24763014
[TBL] [Abstract][Full Text] [Related]
12. ADAMTS-13 antigen and activity levels in thrombocytopenic disorders including thrombotic thrombocytopenic purpura in Kuwait.
Al-Awadhi AM; Jadaon MM; Al-Jafar HA; Al-Wazzan HJ
Acta Haematol; 2011; 125(3):160-6. PubMed ID: 21196718
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
14. The course of ADAMTS-13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine.
Böhm M; Betz C; Miesbach W; Krause M; von Auer C; Geiger H; Scharrer I
Br J Haematol; 2005 Jun; 129(5):644-52. PubMed ID: 15916687
[TBL] [Abstract][Full Text] [Related]
15. Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies: diagnostic experience 2001/2002 of a single research laboratory.
Studt JD; Kremer Hovinga JA; Alberio L; Bianchi V; Lämmle B
Swiss Med Wkly; 2003 Jun; 133(23-24):325-32. PubMed ID: 12923683
[TBL] [Abstract][Full Text] [Related]
16. Atypical presentations of thrombotic thrombocytopenic purpura: a review.
Sarode R
J Clin Apher; 2009; 24(1):47-52. PubMed ID: 19073011
[TBL] [Abstract][Full Text] [Related]
17. Clinical usefulness of a functional assay for the von Willebrand factor cleaving protease (ADAMTS 13) and its inhibitor in a patient with thrombotic thrombocytopenic purpura.
Rick ME; Austin H; Leitman SF; Krizek DM; Aronson DL
Am J Hematol; 2004 Feb; 75(2):96-100. PubMed ID: 14755376
[TBL] [Abstract][Full Text] [Related]
18. Thrombotic thrombocytopenic purpura: survival by "giving a dam".
Moake JL
Trans Am Clin Climatol Assoc; 2004; 115():201-19. PubMed ID: 17060968
[TBL] [Abstract][Full Text] [Related]
19. [Multi-facetted clinical presentation of thrombotic thrombocytopenic purpura].
Niemann CU; Jurlander J; Daugaard G; Friis-Hansen L
Ugeskr Laeger; 2009 Jan; 171(5):340-2. PubMed ID: 19176177
[TBL] [Abstract][Full Text] [Related]
20. [Rituximab provided long-term remission in a patient with severe thrombotic thrombocytopenic purpura refractory to plasma exchange].
Hong H; Aoyama Y; Yamamura R; Ohta T; Mugitani A; Yamane T; Hino M; Matsumoto M; Fujimura Y
Rinsho Ketsueki; 2006 Dec; 47(12):1528-32. PubMed ID: 17233471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
